chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had the expected pain in the arm and shoulder where the vaccine was administered starting the day after the shot. Since then I have had an increase in joint paint in my left shoulder (normally non-existent or very mild) and right ankle where I have had previous injuries from military service. My back has also been "out" more frequently, for lack of a better term, which does give me trouble, however, is normally only once or twice per year. I have also had new joint pain in my knees, right shoulder, my left ankle, and my hips, which normally don't bother me. If I sit for 10-20 minutes I have to move slowly and painfully upon standing and walking, I would call this more extreme pain which subsides back to the normal pain once I'm moving around. I have also experienced an increase in severe headaches and an almost constant mild headache since receiving the vaccine.
Vomiting nonstop for 7 hours straight; Chills; Body aches; This spontaneous case was reported by a patient and describes the occurrence of VOMITING (Vomiting nonstop for 7 hours straight), CHILLS (Chills) and MYALGIA (Body aches) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and 026C27A) for COVID-19 vaccination.     Concurrent medical conditions included Acne. Concomitant products included SPIRONOLACTONE for Acne.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021 at 2:55 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-May-2021, the patient experienced VOMITING (Vomiting nonstop for 7 hours straight) and CHILLS (Chills). 13-May-2021, the patient experienced MYALGIA (Body aches). At the time of the report, VOMITING (Vomiting nonstop for 7 hours straight), CHILLS (Chills) and MYALGIA (Body aches) had not resolved.            treatment for the events included Pepto-Bismol Action taken with mRNA-1273 in response to the events was not Applicable
Initial report was received on 23 August 2012 from a health care professional. A 19 year-old female patient with no reported past medical history had received MENACTRA (lot number, route, site and date of administration not reported) "along with two allergy shots" and an unspecified amount of time after vaccination, experienced an Anaphylactic reaction. No further information was provided at the time of the report. The patient's outcome was not reported. The reporter for this case is the same as for cases 2012-07889 (syncope in a 12-year-old female patient) and 2012-07891 (numbness in left limb down to feet in a female patient). Documents held by sender: None.
-fever to 104 x 4 days, diarrhea x 1 involuntary jerky movement of arm-Treatment
Slight swallowing 40 minutes post first vaccine. Seven and a half hours later, nausea, cold sweat, and momentarily blacked out.
On 11/15/2023 pt contacted pharmacy to report redness and itching on same arm she received vaccination. Denied: swelling, warm to touch, difficulty breathing or swallowing, previous reaction to any other vaccination.  Later on 11/15/2023, presented to pharmacy and presented rash to RPH. Pt presented with flat erythematous lesion on left anterior arm region, initiating approximately half way between shoulder and elbow and extending diagnoally to posterior arm region roughly 6-8 inches above elbow. Pt contact PCP and was told to apply hydrocortisone cream to area.   On 11/17/2023, pt contacted pharmacy to seek further recommendation, reporting rash was still present but now warm to the touch and swollen, reported rash has decreased in size. Denied: difficulty breathing or swallowing, broken skin, elevated temperature. Pt inquired if she had a staph infection, pt was instructed to seek medical attention from PCP or urgent care.
Numbness in left arm 4 minutes after receiving the vaccine, improved after observation for 30 minutes
Pt was inadvertently given 1ml of FLUZONE (instead of correct 0.5 ml dose).  Pt said arm was itchy intermittently x 1 wk but it has resolved.
Narrative: Patient is a 31-year old male who around 330 received his first dose of Covid vaccine. Patient states he felt lightheaded dizzy felt like his throat was swollen along with short of air and chest pressure This all started around 340. Patient states he still having chest pressure. Patient still feels like his throat is swelling. No treatment prior to arrival. Patient's not had reactions before.Pt give prednisone, benadryl & pepcid oral & RX to go home. Pt discharged from ER with no issues.
Mild sensation of ringing in the ear (before 2nd dose); sore  after 1st arm dose; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Mild sensation of ringing in the ear (before 2nd dose)) and VACCINATION SITE PAIN (sore  after 1st arm dose) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No medical history and concomitant drug information provided by reporter.     On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Mild sensation of ringing in the ear (before 2nd dose)) and VACCINATION SITE PAIN (sore  after 1st arm dose). At the time of the report, TINNITUS (Mild sensation of ringing in the ear (before 2nd dose)) and VACCINATION SITE PAIN (sore  after 1st arm dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No medical history and concomitant drug information provided by reporter.   This case was linked to MOD-2021-248516 (Patient Link).
Patient reported extreme fatigue the night she receive the vaccination. 3 days after vaccination pt reports Unusual tingling in leg and sudden numbness in hand. Then her gums felt numb. All of this came and went quickly, within a 20 minute period. There was pain and redness at the injection site reported this day too. 6 days after injection pt reports some redness and soreness at injection site still.
1 hr after vaccine-red and sore at site and swelling at site into upper arm and neck. Today arm sore, swollen and tender to use.
Patient reported about an hour after the injection she developed a dry mouth, lip felt swollen, and she had a metallic taste in her mouth.
Pt. mother reported child ran 103' fever after shots were given on 6/11/19. Treated with Tylenol. Fever lasted until 6/12/19 in late evening.
Information has been received from a registered nurse concerning multiple unspecified patient of unknown age and gender. the patients' concurrent conditions, medical histories and concomitant therapies were not provided,. On unspecified dates, since June  2016 through 31-AUG-2016, the patients were vaccinated with doses of improperly stored GARDASIL 9 (lot # L013429, expiration date 21-JUL-2017; strength, dose, frequency and route were unknown), which were exposed to temperature excursion of 0 degree centigrade for 1 minute, max 7 degree centigrade for a worst case scenario of 450 hours. There were no previous temperature excursions. No data logger was involved. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one several reports received from the same reporter. Additional information has been requested.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Apr2022 at 12:00 as dose 4 (booster), single (Lot number: FP4554) at the age of 78 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: EZETIMIBE; HYDROCHLOROTHIAZIDE; LOSARTIN; MYRBETRIQ; ROSUVASTIN. Past drug history included: Amoxicillin, reaction(s): "Known allergies: Amoxicillin"; Thimerisol, reaction(s): "Known allergies:Thimerisol"; Sulfur, reaction(s): "Known allergies:Sulfur". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Treatment included antiviral product (start date:07Jul2022, stop date: 12Jul2022). When the patient appeared to be fully recovered and her Covid symptoms were mild cold and a little lethargy and when she was ready to end a 10 day quarantine, she had developed a bad cold.
Temperature of 105.6 for four or five hours; Patient threw up; Started to feel uncomfortable/Patient was feeling under the weather; Patient had shivers; nausea; visual effects; This is a spontaneous report from a contactable consumer (Parent) and from a Pfizer sponsored program regulatory authority from a contactable consumer. A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration on 27Mar2021 at 10:30 (at the age of 36 years old) (Batch/Lot number was not reported) as DOSE 2, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 for COVID-19 immunization on an unknown date. The patient experienced temperature of 105.6 for four or five hours on 27Mar2021; threw up and started to feel uncomfortable on 27Mar2021 the same evening of the vaccine; patient had shivers, felt under the weather, nausea and visual effects on an unspecified date (nausea, shivering and visual effects lasted 6 days). The patient underwent lab tests and procedures which included body temperature: 105.6 on 29Mar2021. The clinical outcome of the events pyrexia was recovered on 29Mar2021, vomiting was recovered on 27Mar2021; and malaise, chills, nausea and visual impairment was recovered on an unknown date.   The lot numbers for the vaccine, BNT162B2 was not provided and will be requested during follow up.
Severe chills, shaking. Bowel distress, vomiting. Loss of blood pressure. Migraine, fatigue
Information regarding PREVNAR 13 was received from a nurse regarding a 34 month old female patient who experienced swelling of leg, from the knee to the thigh, which was warm to the touch. At 34 months of age, the patient received a dose on 17 Sep 2010. MEDICAL HISTORY: Relevant medical history was not provided. PRODUCT DETAILS: Indication for PREVNAR 13 was immunisation. Product was administered on 17 Sep 2010. Dose regimen 1 dose 1 time per day. CONCOMITANT THERAPY: Concomitant medications were not reported. EVENT DETAILS: The patient experienced swelling of leg, from the knee to the thigh, which was warm to the touch on 17 Sep 2010. Diphenhydramine was administered as treatment, which helped a little. The outcome is unknown. No additional information was available at the time of this report.
This case was reported by healthcare professional and described the occurrence of vertigo in a 21-year-old female subject who was vaccinated with Flulaval, GlaxoSmithKline for prophylaxis. The subject's medical history included depression, gastroesophageal reflux disease, high cholesterol, reflux unspecified and seasonal allergy. Concurrent medications included Fluoxetine hydrochloride (Prozac), Clonazepam (Klonopin), Rosuvastatin calcium (Crestor), Flexofenadine hydrochloride (Allegra) and Omeprazole (Prilosec). In 2003, the subject received a dose of Flulaval (unknown). At an unspecified time after vaccination with Flulaval, the subject experienced nausea. The outcome was unknown. On 12 September 2009, the subject received a dose of Flulaval (.5 ml, unknown, left arm). On 12 September 2009 less than one day after vaccination with Flulaval, the subject experienced vertigo, low grade fever local swelling. The subject received the Flulaval vaccine. Shortly after receiving the injection, the subject developed a low-grade fever, local swelling and nausea that turned into vertigo. The reporter stated that as of now, the subject does not have a fever but the other symptoms have worsened. She says that the subject's blood pressure is fine. At the time of reporting, the fever resolved, while the swelling, nausea and vertigo were worse. The healthcare professional considered the events were probably related to vaccination with Flulaval.
chills, t102.2 fever, tired & weak 1 wk p/vax;
PERIPHERAL NEUROPATHY 6/30/2022 JAUNDICE         ACUTE NON ST ELEVATION MI 5/9/2022 JAUNDICE  TYPE 2 MI 4/14/2022 JAUNDICE  PERIPHERAL NEUROPATHY 6/30/2022 ANEMIA  ACUTE NON ST ELEVATION MI 5/9/2022 ANEMIA  TYPE 2 MI 4/14/2022 ANEMIA  PERIPHERAL NEUROPATHY 6/30/2022 DEHYDRATION  ACUTE NON ST ELEVATION MI 5/9/2022 DEHYDRATION  TYPE 2 MI 4/14/2022 DEHYDRATION  PERIPHERAL NEUROPATHY 6/30/2022 ELEVATED TROPONIN I  ACUTE NON ST ELEVATION MI 5/9/2022 ELEVATED TROPONIN I  TYPE 2 MI 4/14/2022 ELEVATED TROPONIN I
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with PNEUMOVAX 23, .5 ml, intramuscular. Anatomical location, lot number and expiration were not reported. On an unknown date the patient experienced injection site pain. The patient was afebrile. No treatment was provided. The outcome of injection site pain is unknown. The reporter did not provide the relatedness of injection site pain for PNEUMOVAX 23. This case was linked to cases 1303USA005018, 1304USA002367 and 1304USA002378, based on the same reporter. Additional information is not expected.
Extreme body aches, fever in excess of 100, chills, and profuse sweating.  Nausea and extreme fatigue.  Symptoms lasted from Wednesday morning 4/21/2021 through Saturday 04/24/2021.
pt states after getting 1st  Covid Vax he started having short term memory loss.  He was having problems remembering peoples names and started having speech issues.  He went to the Hospital.  He had some test and was diagnosed with having a stroke. He was hospitalized for a few days. He got his 2nd Covid Vax on 6/14/21.  He had his 1st Covid booster shot on 1/10/22.  After getting vaccinated later that day he collapsed. His right and right leg were paralyzed causing him to fall.  He was taken to Hospital.  He had testing and it was determined he had a blood clot in the brain.  He was given an IV with blood thinner.  He was then given injections and then pill form for blood thinner.  He was admitted to the hospital and then transferred to a rehab for about a week and then released to home. He has moved to a new location in CT and is seeing a new physician which has done blood work.  He was told he would be referred to a Hematologist.
PATIENT PRESENTED TO CLINIC FOR DOSE 2 OF COVID-19 AT 0920 (PFIZER LOT NUMBER ER8734 EXP 07/2021).  AFTER RECEIVING COVID VACCINE DOSE 2, PATIENT COMPLAINT OF "STIFFNESS" ON RIGHT NECK AND "DIFFICULTY TAKING DEEP BREATHS".  PATIENT DENIES OTHER S/S.  PATIENT TRANSPORTED TO ED BY WHEELCHAIR FOR FURTHER EVALUATION.
Information has been received from a physician concerning a female who was vaccinated with a dose of GARDASIL.  Subsequently the patient experienced a seizure.  At the time of the report the patient's outcome was unknown.  Upon internal review, seizure was considered to be an other important medical event.  Additional information has been requested.
high (102F) fever for two days after vax, extreme fatigue/weakness for another two days, then some fatigue for another 3-4 days, then intermittent shortness of breath and an inability to exercise at normal levels (normal = 2 mile jog twice weekly) until a month after vaccination
Patient was fully vaccinated 3/11/21 and 4/1/21 with Pfizer. She presents via EMS to the ER reporting shortness of breath, cough, body aches states that symptoms started yesterday. She is still admitted with COVID 19 since 1/19/22
I lost consciousness; hitting my head; bruising body; when I had my blood pressure taken it was over 200 landing me in ER overnight to try to get my BP down; suffering with Arrhythmia; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 22Feb2021 (lot number: EN6201) as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL9261), administered in the right arm on 01Feb2021 12:00 AM for COVID-19 immunisation and experienced achy body, tiredness, fever and chills. After the second vaccine early in the next morning (23Feb2021) around 3 am, the patient lost consciousness when retuning from the bathroom hitting her head and bruising body. She lay on the floor for approximately 15-20 minutes. She was ordered by her primary care physician to have a brain scan but when she had her blood pressure taken it was over 200 landing her in emergency room (ER) overnight to try to get her BP down. She was now on beta blockers and was still suffering with arrhythmia awaiting an appointment with her new cardiologist. She was hospitalized for 2 days due to the events. She had no COVID prior vaccination and has not tested COVID post vaccination. She has no other vaccine in four weeks. Therapeutic measures were taken as a result of the events. The outcome of the events were not recovered.
fever; sore arm; This case was reported by a consumer via call center representative and described the occurrence of fever in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever and pain in arm. On an unknown date, the outcome of the fever and pain in arm were unknown.   It was unknown if the reporter considered the fever and pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, after vaccination, the patient experienced fever and sore arm. No other details or specifics were available. The reporter stated that, ended the call before collection of answers to questions. The reporter did not consent to follow up.
She got her Dtap vaccine, she felt fine initially.  Within 10 minutes of her drive home her stomach started cramping, and then had a headache.  She got home, had loose stool and then felt like she was going to throw up and was dry heaving.  She felt nauseated as well, and then had some diarrhea.  Her stomach then cramped a little the rest of the day, but she has been fine ever since the following day.  When she went to get the vaccine she answered yes to latex, and she had also eaten within 30 minutes of getting the vaccine.  She called and told the pharmacist and was told that it was not usually symptoms, but did tell her it was listed on the printout she was given.  She also informed her doctor of this and she informed her that it was a reaction.  Her arm has not been sore or stiff, just the stomach issues.
Ten minutes following injection: shortness of breath, stridor, (oxygen saturation 86% sacral urticaria. Prompt improvement with epinephrine
Initial report received on 7/19/06 from an investigator participating in the above mentioned trial. A 53 year old male subject with a history of obesity, type 2 diabetes with peripheral circulatory disorder and neurologic manifestations, peripheral edema, hypertension ans stroke (1996), experienced respiratory difficulty 68 days after he had received an injection of Adacel, lot number C2341AA. The following day, the subject presented to an ER with respiratory distress and guppy breathing. On exam, the subject suffered a cardiac arrest. Resuscitative efforts were impaired by airway difficulties (Copious vomitus and difficult intubation). He was treated with IV epinephrine and atropine. Resuscitative efforts were unsuccessful, and the subject died. Per the investigator, the serious adverse event was cardiac arrest due to pulmonary edema. No autopsy was to be performed. This case was not considered a coroners case per the coroners office. According to the investigator, the event was not related to the study vaccine. Documents held by sender Emergency room report.
1 of 2 pts, who was hospitalized this yr (1992) for 1 wk p/contracting epiglotitis; both pts had event simultaneously;
On 6/1/01, temperature of 103.2F. Tylenol given and it went down to 100F. The next day, it was 102.2F and decreased to 99F with Tylenol. The next day, up again to 102.2F. Per mom, today is down to 99F-97F. "Torso was covered with rash and small red bumps."
pale, hyporesponsive, shocky, cold, emesis for about 1-2 hrs; t95; (onset 24 hrs p/vax);  fever;
Attempted to give IM flu shot. Pt moved leg between father's leg. Approximately 3/4 was given but unknown of what total was given as some was running down pts leg as well. Pt is coming back in November to be given another flu shot with 2nd Hep. A.
Information regarding Prevenar (pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein) injection) was received from a healthcare professional regarding a patient who received improperly stored vaccine. The patient received a dose on an unspecified date. Relevant medical history was not provided. Indication for Prevnar was immunization. Product was administered on an unspecified date. Dose regimen was unspecified. Concomitant medications were not reported. The patient received Prevnar that was improperly stored (medication error). The temperature of the refrigerator was noted to be at least 20 degrees F. No additional information was available at the time of this report.
Severe headache, nausea and vomiting, loose stools; injection site is sore, red, hot, and swollen.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 12-JAN-2018, the patient was vaccinated with an expired dose of ZOSTAVAX lot # M039452; expiry date 19-DEC-2017 (dose and route of administration were not provided). The ZOSTAVAX was reconstituted with sterile diluent. No adverse effect was reported.
Symptoms began with fever, sneezing, watery eyes and runny nose.  Progressed over the next 7 days to include recurrent fever up to 101, chills, joint pain, fatigue, sinus congestion, sore throat, wheezing, barking cough with mucous, chest congestion. Still contending w/chest/sinus congestion and cough.  The only other time I received a flu vaccine (~1993), I ended up getting the flu.  I will never receive another flu vaccine, it guarantees I get the flu!
Child hospitalized for uncontrollable crying. All tests came back negative according to doctor at hospital. The hospital discharge summary states immunization reaction.
Soreness at the injection site, redness at the injection site, redness/rash from elbow to injection site, swelling and redness at collar bone
The patient complained of tightening of the throat and mid-chest pain started at 5:30. She had a tightening of the throat reaction from dose 1 of Moderna. Her provider prescribed Benadryl and Epipen in case another reaction occurs on the 2nd dose. She took Benadryl 30 minutes prior to her appointment
CHEST PAIN/PALPITATIONS AND ELEVATED BLOOD PRESSURE TO 200S SYSTOLIC